Article | February 7, 2022

How Rare Diseases Were Affected By The COVID Pandemic

Source: THREAD

By Joyce Moore, Head of Rare Disease Solutions, THREAD


The latest issue of Raconteur (published as a supplement in The Times, UK) took a deep look at the rare disease landscape, including how rare diseases were affected by the COVID pandemic, and how patients who are engaged in the drug development process through clinical trials can build connections through digital platforms. It also highlighted how the increasing use of decentralized clinical trials (DCTs) is poised to improve both the patient experience and outcomes in the coming years. 

To learn more about THREAD, visit their Clinical Leader page.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader